The UMD-FBN1 mutations database
Record ID: 188

Mutation description


Variation name (cDNA level)Variation name (protein level)Variation statusVariation class
c.IVS63+5G>A (c.8051+5G>A)HeterozygousMutation

wt codonwt aamutant codonmutant aamutational eventmutation type
GGGGlyspl+5Spl.G->ATs

StructureKey Residue (HCD)Pyrimidin doubletCpG
cb EGF-like #43 

Mutation impact


At the mRNA levelOn restriction map
Skipping of exon 63, frameshiftNew restriction site(s): none
Lost restriction site(s): none

Impact on splicing
Splice site type Wild type sequence CV Mutant type sequence CV Variation (%)
Donor
AGGgtaagc
92 _
AGGgtaaac
79.9 _ *
-13.2 %

Patient and sample data


Sample IDPatient statusGenderTransmissionAge of onsetAge of deathGeographic origin
USA05HOU F0006 I01ProbandNAde novo? (8 years old)U.S.A

Phenotypic groupDisease
NAClassical MFS

Clinical data


Symptom
C-Mitral valve prolapse
O-Ectopia lentis
O-Myopia
S-Arachnodactyly (M)
S-Arm span/height >1.05 (M)
S-Dolichostenomelia
S-Long bone over growth
S-Pectus carinatum (M)(2)
S-Reduced US/LS ratio <0.87 (M)

Reference


Reference IDPubMed IDReference
24-
Grossfield J, Cao S; Milewicz DM. "Characterization of mutations involving the carboxy-terminal domain of fibrillin-1 indicates a role of this domain in secretion in dermal fibroblasts". Am J Hum Genet 1993, 53 abstract 1167.